“The trial has two interim data analysis points, the second of which may enable accelerated marketing approval.”
Part 2- 144 patients @ 35 weeks…
Ann: ACTION3 IND Approved in China, page-95
-
- There are more pages in this discussion • 137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
-0.015(2.78%) |
Mkt cap ! $288.8M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 54.0¢ | 51.0¢ | $1.930M | 3.666M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 136 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 28650 | 2 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |